Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical trial is to study the comparative effect of a classical unani antiobesity drug safoof-e-muhazzil on hyperlipidemia in its classical powder form and in compressed tablet form against a standard control.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Jamia Hamdard University
• Treatments: Atorvastatin; Atorvastatin Calcium

Criteria

Inclusion Criteria:

• Age 20 Year(s) To 70 Year(s)

• Gender Both

• participate in Clinical Trial voluntarily.

• Hyperlipidemic

Exclusion Criteria:

• Persons below 20 yrs and Above 70 yrs of age

• Pregnancy

• Liver diseases

• Renal diseases

• Diabetes mellitus Type II

• Alcoholic

• AIDS

• Thyroid Disease

• Drug intake ? Corticosteroids, Diuretics, Beta-blockers, Oral contraceptives, Cyclosporin, Androgens & Retinoids